1.Korean guidelines for the management of gout
Jennifer Jooha LEE ; Ji Soo LEE ; Min Kyung CHUNG ; Joong Kyong AHN ; Hyo-Jin CHOI ; Seung-Jae HONG ; Chong-Hyeon YOON ; Su-Hyun KIM ; Kyung-Hwan JEONG ; Jong-Woo KIM ; Bo-Yeon KIM ; Jin-Ho SHIN ; Woo Gyu KIM ; Soo-Young KIM ; Hyun-Jung KIM ; Jeong-Soo SONG ; Jae-Bum JUN ; Hyun-Ah PARK ; Shung Chull CHAE ; Bum Soon CHOI ; Tae Nyun KIM ; Hyun Ah KIM
Journal of Rheumatic Diseases 2023;30(3):141-150
Gout is the most common form of arthritis, with the prevalence increasing worldwide. The present treatment guidelines provide recommendations for the appropriate treatment of acute gout, management during the inter-critical period, and prevention of chronic complications. The guidelines were developed based on evidence-based medicine and draft recommendations finalized after expert consensus. These guidelines are designed to provide clinicians with clinical evidence to enable efficient treatment of gout.
2.Korean guidelines for the management of gout
Jennifer Jooha LEE ; Ji Soo LEE ; Min Kyung CHUNG ; Joong Kyong AHN ; Hyo-Jin CHOI ; Seung-Jae HONG ; Chong-Hyeon YOON ; Su-Hyun KIM ; Kyung-Hwan JEONG ; Jong-Woo KIM ; Bo-Yeon KIM ; Jin-Ho SHIN ; Woo Gyu KIM ; Soo-Young KIM ; Hyun-Jung KIM ; Jeong-Soo SONG ; Jae-Bum JUN ; Hyun-Ah PARK ; Shung Chull CHAE ; Bum Soon CHOI ; Tae Nyun KIM ; Hyun Ah KIM
The Korean Journal of Internal Medicine 2023;38(5):641-650
Gout is the most common form of arthritis, with the prevalence increasing worldwide. The present treatment guidelines provide recommendations for the appropriate treatment of acute gout, management during the inter-critical period, and prevention of chronic complications. The guidelines were developed based on evidence-based medicine and draft recommendations finalized after expert consensus. These guidelines are designed to provide clinicians with clinical evidence to enable efficient treatment of gout.
3.The Distribution of Multidrugresistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study
Youjin CHANG ; Kyeongman JEON ; Sang-Min LEE ; Young-Jae CHO ; Young Sam KIM ; Yong Pil CHONG ; Sang-Bum HONG
Journal of Korean Medical Science 2021;36(41):e251-
Background:
It is essential to determine the distribution of the causative microorganisms in the region and the status of local antibiotic resistance for the proper treatment of hospitalacquired pneumonia/ventilator-associated pneumonia (HAP/VAP). This study aimed to investigate the occurrence and causative strains of HAP/VAP, distribution of resistant bacteria, use of antibiotics, and the ensuing outcomes of patients in Korea.
Methods:
A multicenter prospective observational cohort study was conducted among patients with HAP/VAP admitted to the medical intensive care unit of 5 tertiary referral centers between August 2012 and June 2015. Patients' demographic and clinical data were collected.
Results:
A total of 381 patients were diagnosed with HAP/VAP. Their median age was 69 (59–76) years and 71% were males. A majority of the patients (88%) had late-onset (> 5 days) HAP/VAP. One-quarter of the patients (n = 99) had at least one risk factor for multidrug-resistant (MDR) pathogens, such as prior intravenous antibiotic use within the last 90 days. Microbiological specimens were mostly obtained noninvasively (87%) using sputum or endotracheal aspirates. Pathogens were identified in 235 (62%) of the 381 patients. The most common bacterial pathogen was Acinetobacter baumannii (n = 89), followed by Staphylococcus aureus (n = 52), Klebsiella pneumoniae (n = 25) and Pseudomonas aeruginosa (n = 22). Most of isolated A. baumannii (97%) and S. aureus (88%) were multidrug resistant. The most commonly used empirical antibiotic regimens were carbapenem-based antibiotics (38%), followed by extended-spectrum penicillin/ β-lactamase inhibitor (34%). Glycopeptide or linezolid were also used in combination in 54% of patients. The 28-day mortality rate of the patients with HAP/VAP was 30% and the 60-day mortality was 46%. Patients who used empirical antibiotics appropriately had significantly lower mortality rates than those who did not (28-day mortality: 25% vs. 40%, P = 0.032; 60-day mortality: 41% vs. 55%, P = 0.032, respectively). Administration of appropriate empirical antibiotics (odds ratio [OR], 0.282; confidence interval [CI], 0.092–0.859; P = 0.026), Day 7 treatment failure (OR, 4.515; CI, 1.545–13.192; P= 0.006), and APACHE II score on day 1 (OR, 1.326; CI, 0.988–1.779; P = 0.012) were the factors that determined the 28-day mortality in patients with HAP who had identified bacteria as pathogens.
Conclusion
In HAP/VAP patients, there was a large burden of MDR pathogens, and their associated mortality rate was high. Proper selection of empirical antibiotics was significantly associated with the patient's prognosis; however, there was a discrepancy between major pathogens and empirical antibiotic therapy.
4.A Combined Closing Wedge Distal Femoral Osteotomy and Medial Reefing Procedure for Recurrent Patellar Dislocation with Genu Valgum.
Chong Bum CHANG ; Gautam M SHETTY ; Jong Seong LEE ; Young Chan KIM ; Jae Ho KWON ; Kyung Wook NHA
Yonsei Medical Journal 2017;58(4):878-883
PURPOSE: Recurrent patellar dislocation is often associated with genu valgum. The purpose of this study was to analyze the short-term results of single-incision, closing-wedge distal femoral osteotomy (CWDFO) combined with medial reefing and lateral release for recurrent patellar instability with genu valgum. MATERIALS AND METHODS: Combined CWDFO/medial reefing/lateral release was performed on 10 knees. Clinical evaluation was based on pre- and postoperative Knee Society Score (KSS) and Kujala patellofemoral score. Radiographic evaluation was performed with reference to the weight-bearing line (WBL), the femorotibial angle (FTA), and the mechanical lateral distal femoral angles in the knee-standing view. RESULTS: At a mean follow-up of 20±11.7 months (range, 12–42 months), KSS scores improved significantly, from 46.7±5.2 preoperatively to 87±4.4 postoperatively (p<0.001), as did the Kujala score, from 44±8 preoperatively to 86.6±6.8 postoperatively (p<0.001). The WBL decreased significantly, from 76±7% preoperatively to 41±11% postoperatively (p<0.001). The FTA was improved significantly, from 12.7±1.7° preoperatively to 4±4° postoperatively (p<0.001), as was the mLDFA, from 83±4° preoperatively to 91±1.3° postoperatively (p<0.001). CONCLUSION: Use of single-incision CWDFO combined with medial reefing and lateral release prevents patellar dislocation, corrects deformity, and improves clinical outcomes.
Congenital Abnormalities
;
Follow-Up Studies
;
Genu Valgum*
;
Knee
;
Osteotomy*
;
Patellar Dislocation*
;
Weight-Bearing
5.Reoperative Aortic Root Replacement in Patients with Previous Aortic Root or Aortic Valve Procedures.
Byung Kwon CHONG ; Sung Ho JUNG ; Suk Jung CHOO ; Cheol Hyun CHUNG ; Jae Won LEE ; Joon Bum KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2016;49(4):250-257
BACKGROUND: Generalization of standardized surgical techniques to treat aortic valve (AV) and aortic root diseases has benefited large numbers of patients. As a consequence of the proliferation of patients receiving aortic root surgeries, surgeons are more frequently challenged by reoperative aortic root procedures. The aim of this study was to evaluate the outcomes of redo-aortic root replacement (ARR). METHODS: We retrospectively reviewed 66 patients (36 male; mean age, 44.5±9.5 years) who underwent redo-ARR following AV or aortic root procedures between April 1995 and June 2015. RESULTS: Emergency surgeries comprised 43.9% (n=29). Indications for the redo-ARR were aneurysm (n=12), pseudoaneurysm (n=1), or dissection (n=6) of the residual native aortic sinus in 19 patients (28.8%), native AV dysfunction in 8 patients (12.1%), structural dysfunction of an implanted bioprosthetic AV in 19 patients (28.8%), and infection of previously replaced AV or proximal aortic grafts in 30 patients (45.5%). There were 3 early deaths (4.5%). During follow-up (median, 54.65 months; quartile 1–3, 17.93 to 95.71 months), there were 14 late deaths (21.2%), and 9 valve-related complications including reoperation of the aortic root in 1 patient, infective endocarditis in 3 patients, and hemorrhagic events in 5 patients. Overall survival and event-free survival rates at 5 years were 81.5%±5.1% and 76.4%±5.4%, respectively. CONCLUSION: Despite technical challenges and a high rate of emergency conditions in patients requiring redo-ARR, early and late outcomes were acceptable in these patients.
Aneurysm
;
Aneurysm, False
;
Aorta
;
Aorta, Thoracic
;
Aortic Valve*
;
Disease-Free Survival
;
Emergencies
;
Endocarditis
;
Follow-Up Studies
;
Generalization (Psychology)
;
Humans
;
Male
;
Reoperation
;
Retrospective Studies
;
Sinus of Valsalva
;
Surgeons
;
Transplants
6.The Usefulness of Critical Pathway in Laparoscopic Cholecystectomy.
Jae Uk CHONG ; Jung Bum CHOI ; Mi Ae SEO ; Su Ji LEE ; Ja Hye CHEON ; Kyung Sik KIM
Journal of Minimally Invasive Surgery 2016;19(2):57-62
PURPOSE: Under the rising demand of health services, the critical pathway (CP) which standardizes the practice guideline was introduced as a means to provide quality healthcare service. CP may increase the patient's satisfaction rate by providing systematic and consistent service. We aimed to evaluate the significance of CP by development and application of CP to patients undergoing laparoscopic cholecystectomy. METHODS: From June 2010 to July 2011, 148 patients underwent elective laparoscopic cholecystectomy. Patients were divided into two groups, including 57 patients in the CP group and 91 patients in the non-CP group. In a retrospective review, related hospital costs were analyzed and compared for both groups. Survey results on satisfaction for the CP group were also analyzed. RESULTS: The mean age was 22.7 years in the CP group and 37.9 years in the non-CP group. Number of hospitalized days was one day for the CP group and 2.51 days for the Non-CP group with p<0.001. In cost analysis all variables showed a significant reduction in the CP group compared to the Non-CP group. The satisfaction rate in the CP group scored 8 points out of 10. CONCLUSION: Results have shown benefit from the financial point of the view for the CP group. Current inclusion criteria for CP are limited and still in development for a solid protocol. Further efforts with a large-scale comparative study to broaden the indication for CP are desired.
Cholecystectomy
;
Cholecystectomy, Laparoscopic*
;
Costs and Cost Analysis
;
Critical Pathways*
;
Delivery of Health Care
;
Health Services
;
Hospital Costs
;
Humans
;
Retrospective Studies
7.Gastrointestinal Risk Factors and Non-steroidal Anti-inflammatory Drugs Use in Rheumatoid Arthritis and Osteoarthritis Patients in Korea.
Eun Young LEE ; Seung Jae HONG ; Yong Beom PARK ; Kyung Su PARK ; Chan Bum CHOI ; Chang Keun LEE ; Ran SONG ; Yun Jong LEE ; Chang Hee SUH ; Hyun Ah KIM ; Jun Ki MIN ; Chong Hyeon YOON ; Won PARK ; Won Tae CHUNG ; Geun Tae KIM ; Jung Yoon CHOE ; Seong Wook KANG ; Yong Wook PARK ; Wan Hee YOO ; Sang Heon LEE
Journal of Rheumatic Diseases 2016;23(1):47-54
OBJECTIVE: The aim of this study was to examine and compare the gastrointestinal (GI) risk factors and treatment patterns of rheumatoid arthritis (RA) and osteoarthritis (OA) patients in Korea. METHODS: This was a cross-sectional, observational study on RA and OA patients taking non-steroidal anti-inflammatory drugs (NSAIDs) for at least 1 month. A total of 1,896 patients (981 RA patients, 915 OA patients) were recruited from 20 university hospitals. Data were collected through medical records and patient surveys. GI risk factors included age, prolonged (over 3 months) or high-dose use of NSAIDs, alcohol drinking, smoking, use of aspirin, anticoagulants or glucocorticoids, comorbidities, and history of Helicobacter pylori infection or other GI complications. Treatment patterns were classified according to groups using, selective cyclooxygenase (COX)-2 inhibitors+/-gastro-protective agents, non-selective COX-2 inhibitors+proton pump inhibitor, or non-selective COX-2 inhibitors+/-other gastro-protective agents. RESULTS: GI risk factors were highly present in both RA and OA patients. The proportion of prolonged use of NSAIDs, smoking, and glucocorticoid use were higher in RA patients (p<0.001). The proportion of comorbidities and use of aspirin were higher in OA patients (p<0.001). The remaining GI risk factors were present in similar proportions in both groups. Use of selective COX-2 inhibitors or gastro-protective agents was higher in RA patients. CONCLUSION: Prolonged use of NSAIDs and concomitant glucocorticoid use were higher in RA patients, while comorbidities and concomitant aspirin use were predominant in OA patients. These results will provide insights for use in development of future guidelines for proper selection of NSAIDs and effective prevention of GI complications in arthritis patients.
Alcohol Drinking
;
Anti-Inflammatory Agents, Non-Steroidal
;
Anticoagulants
;
Arthritis
;
Arthritis, Rheumatoid*
;
Aspirin
;
Comorbidity
;
Cyclooxygenase 2 Inhibitors
;
Glucocorticoids
;
Helicobacter pylori
;
Hospitals, University
;
Humans
;
Korea*
;
Medical Records
;
Observational Study
;
Osteoarthritis*
;
Prostaglandin-Endoperoxide Synthases
;
Risk Factors*
;
Smoke
;
Smoking
8.Multiple Ascending Aortic Mural Thrombi and Acute Necrotizing Mediastinitis Secondary to Acute Pancreatitis.
Byung Kwon CHONG ; Jae Kwang YUN ; Joon Bum KIM ; Do Hyun PARK
The Korean Journal of Thoracic and Cardiovascular Surgery 2016;49(5):401-404
The formation of aortic thrombi is an extremely rare complication of acute pancreatitis. Here we report a case of acute pancreatitis complicated by a paraesophageal pseudocyst, necrotizing mediastinitis, and the formation of multiple thrombi in the ascending aorta. The patient was successfully treated by surgical therapy, which included extensive debridement of the mediastinum and removal of the aortic thrombi under cardiopulmonary bypass. Although esophageal resection was not carried out concomitantly, the lesions were resolved and the patient remained free of complications over 2 years of follow-up care.
Aorta
;
Cardiopulmonary Bypass
;
Debridement
;
Esophageal Diseases
;
Follow-Up Studies
;
Humans
;
Mediastinitis*
;
Mediastinum
;
Pancreatitis*
;
Pancreatitis, Acute Necrotizing
;
Thrombosis
9.Erratum to: The Usefulness of Critical Pathway in Laparoscopic Cholecystectomy.
Jae Uk CHONG ; Jung Bum CHOI ; Mi Ae SEO ; Su Ji LEE ; Ja Hye CHEON ; Kyung Sik KIM
Journal of Minimally Invasive Surgery 2016;19(4):165-165
Authors requested to change the name of the hospital to proper name.
10.Part 2. Adult basic life support: 2015 Korean Guidelines for Cardiopulmonary Resuscitation.
Keun Jeong SONG ; Jae Bum KIM ; Jinhee KIM ; Chanwoong KIM ; Sun Young PARK ; Chang Hee LEE ; Yong Soo JANG ; Gyu Chong CHO ; Youngsuk CHO ; Sung Phil CHUNG ; Sung Oh HWANG
Clinical and Experimental Emergency Medicine 2016;3(Suppl 1):S10-S16
No abstract available.
Adult*
;
Cardiopulmonary Resuscitation*
;
Humans

Result Analysis
Print
Save
E-mail